HIGHFDA DRUG

Duloxetine Delayed-Release Capsules, 20 mg, Rx Only, 60 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-097-06.

CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
April 29, 2026
Status
ACTIVE

Quick Facts at a Glance

Recall Date
April 29, 2026
Hazard Level
HIGH
Brands
DULOXETINE, Ajanta Pharma USA Inc.
Geographic Scope
1 states

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
DULOXETINE, Ajanta Pharma USA Inc.
Model numbers
Lot#: PA10734, Exp. Jun 2026.
UPC codes
27241-097, 27241-098, 27241-164, 27241-099, 27241-097-06, 27241-097-10, 27241-097-90, 27241-097-05 +6 more
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    April 29, 2026

  2. Reported by FDA DRUG

    May 13, 2026

  3. RecallRadar source check

    May 20, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Ajanta Pharma Ltd. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for DULOXETINE recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

Duloxetine Delayed-Release Capsules, 20 mg, Rx Only, 60 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-097-06.. Generic: DULOXETINE; Brand: DULOXETINE. Reason: CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.. Classification: Class II. Quantity: 117,168 packs. Distribution: Nationwide within U.S

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot#: PA10734
Exp. Jun 2026.
UPC Codes
27241-097
27241-098
27241-164
+11 more
Affected States
ALL
Report Date
May 13, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Duloxetine Capsules Recalled Over High N-Nitroso Impurity Risk

Towa Pharmaceuticals recalled 3,397 bottles of Duloxetine Delayed-Release Capsules on November 24, 2025. The recall stems from CGMP deviations resulting in N-nitroso-duloxetine levels exceeding FDA limits. Consumers must stop using the product immediately.

DULOXETINE
CGMP Deviations;
Read more